PYROFEN 250 MG/5 ML ORAL SUSPENSION, 150 ML - Turkey License d415c8a4888883d270dae36e14f6e3ea
Access comprehensive regulatory information for PYROFEN 250 MG/5 ML ORAL SUSPENSION, 150 ML in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number d415c8a4888883d270dae36e14f6e3ea with license number 2022/786and contains active ingredient Parasetamol . The license is held by DEVA HOLDฤฐNG A.ล..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free Database
Powered by Pure Global AI
21,000+ Products
d415c8a4888883d270dae36e14f6e3ea
License Details
Turkey SFDA License: d415c8a4888883d270dae36e14f6e3ea

